Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.Invisalign volume for teenage patients was 104,000 cases, up 6.8% year over year.Revenues from Scanner and Services declined 13.1% to $69.4 million in the quarterdue to COVID-19-led lower sales in North America and APAC region, despite increase in revenues in EMEA and Latin America.MarginsGross margin in the quarter under review contracted 167 basis points (bps) year over year to 71.6% on a 6.6% rise in cost of net revenues.During the quarter, Align Technology witnessed a 14.5% year-over-year increase in selling, general and administrative expenses to $282.9 million and a 10.7% rise in research and development expenses to $41.5 million.